CareDx (CDNA) analyst forecast and price target
Analyst forecast
Consensus of 7 analyst ratings
Based on 3 analyst targets
Recent analyst ratings
| Firm | Action | Rating | Price target | Date |
|---|---|---|---|---|
| BTIG | Maintained | Buy | $74.00 from $60.00 | Sep 24, 2026 |
| Canaccord Genuity | Initiated Coverage | Buy | $65.00 | Sep 2, 2026 |
| BTIG | Maintained | Buy | $60.00 from $45.00 | Aug 6, 2026 |
| HC Wainwright & Co. | Maintained | Neutral | $46.00 | Jul 31, 2026 |
| BTIG | Maintained | Buy | $45.00 from $28.00 | Jul 16, 2026 |
| BTIG | Maintained | Buy | $28.00 from $26.00 | Apr 29, 2026 |
| BTIG | Maintained | Buy | $26.00 from $25.00 | Feb 26, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $21.00 from $18.00 | Feb 25, 2026 |
| Wells Fargo | Maintained | Equal-Weight | $18.00 from $14.00 | Dec 15, 2025 |
| BTIG | Maintained | Buy | $25.00 from $22.00 | Nov 6, 2025 |
| BTIG | Maintained | Buy | $22.00 | Sep 23, 2025 |
| BTIG | Maintained | Buy | $22.00 | Sep 12, 2025 |
| William Blair | Initiated Coverage | Market Perform | — | Aug 26, 2025 |
| Wells Fargo | Maintained | Equal-Weight | $14.00 from $19.00 | Aug 8, 2025 |
| Craig-Hallum | Maintained | Buy | $26.00 from $40.00 | Jul 18, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $25.00 | May 5, 2025 |
| Stephens & Co. | Maintained | Overweight | $40.00 | May 5, 2025 |
| Goldman Sachs | Maintained | Buy | $26.00 from $34.00 | Apr 17, 2025 |
| HC Wainwright & Co. | Maintained | Neutral | $25.00 from $26.00 | Mar 3, 2025 |
| Stephens & Co. | Maintained | Overweight | $40.00 | Feb 27, 2025 |
Frequently asked questions
What is the price target for CDNA stock?
The average 12-month analyst price target for CareDx (CDNA) is $61.67, with a high estimate of $74.00 and a low of $46.00, across 3 analysts.
Is CDNA a buy, sell, or hold?
Analysts covering CareDx currently average a Buy rating: 5 buy, 2 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.
What upside do analysts see for CDNA?
The average price target of $61.67 implies 4.67% downside from the last price of $64.69.
What is the latest analyst rating on CDNA?
On Sep 24, 2026, BTIG maintained CareDx at Buy with a price target of $74.00.
Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.